and XBB.1.5 was higher than RBD-215, Delta, BA.1 and BA.2 being consistent with the evolution of the virus towards better binding to ACE2 and higher infection capability (Ito et al., 2023; Yue et al., 2023). The gene discussed is ACE2; the disease is infection.